Cargando…
Impact of the COVID-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the WHO End TB Strategy at Risk?
Background: In 2014, the World Health Organization (WHO) launched the “post-2015 End TB strategy”, that aims to end the global tuberculosis (TB) epidemic by 2030. However, the COVID-19 pandemic has severely impacted global public health and the strict measures to control the coronavirus spread can a...
Autores principales: | Souza, Mariana do Rosário, da Paz, Wandklebson Silva, Sales, Vinícius Barbosa dos Santos, de Jesus, Gleidson Felipe Hilario, Tavares, Débora dos Santos, Lima, Shirley V. M. Almeida, Sousa, Álvaro Francisco Lopes, de Melo, Enaldo Vieira, do Carmo, Rodrigo Feliciano, de Souza, Carlos Dornels Freire, Bezerra-Santos, Márcio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277074/ https://www.ncbi.nlm.nih.gov/pubmed/35847020 http://dx.doi.org/10.3389/fphar.2022.891711 |
Ejemplares similares
-
Corrigendum: Impact of the COVID-19 pandemic on the diagnosis of tuberculosis in Brazil: Is the WHO end TB strategy at risk?
por: do Rosário Souza, Mariana, et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic on the diagnosis of leprosy in Brazil: An ecological and population-based study
por: da Paz, Wandklebson Silva, et al.
Publicado: (2022) -
Basic and associated causes of schistosomiasis-related mortality in Brazil: A population-based study and a 20-year time series of a disease still neglected
por: Silva da Paz, Wandklebson, et al.
Publicado: (2021) -
Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?
por: do Carmo, Rodrigo Feliciano, et al.
Publicado: (2022) -
A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018
por: de Brito, Rodrigo José Videres Cordeiro, et al.
Publicado: (2022)